. The candidate SNP and TaqMan assay information (GRCh38.p7). 
Exposure Monitoring
First mid-stream urine in the morning were collected and stored at −20 °C until analysis. Four phthalate metabolites (monoethyl phthalate (MEP), monobutyl phthalate (MBP), monobenzyl phthalate (MBzP), and mono(2-ethyl-5-hydroxyhexyl)phthalate (MEHHP)) representing the exposure to four commonly used phthalates (diethylphthalate (DEP), dibutyl phthalate (DBP), butyl benzyl phthalate (BBzP), and di(2-ethylhexyl) phthalate (DEHP)) were measured by ultra-performance liquid chromatography coupled with tandem mass spectrometry (UPLC-MS/MS). The samples passed through 96-well conditioned μ-Elution plates of Oasis WAX (Waters, Milford, MA, USA), washed with 70% methanol, then the analytes were eluted with four times of 25 μL of 0.1% ammonium hydroxide in methanol. The eluent was dried and re-constituted with 100-μL methanol, and two micro-liters of the sample will be injected onto an Ascentis Express C18 column (50 × 2.1 mm, 2.7 μm, (Waters, Milford, MA, USA) with gradient elution using acetonitrile and 0.04% acetic acid(aq) as the mobile phase at a Waters ACQUITY UPLC, and the analytes were detected with a Quattro Premier XE triple-quadrupole mass spectrometer (Waters, Milford, MA, USA) using negative electrospray ionization (ESI-) using multiple reaction monitoring (MRM); two ion transitions of each analyted were acquired to fulfill the requirement of four identification points. The accuracy and precision of the analysis on real samples were based on two matrix spike samples (for accuracy and repeatability), sample duplicate (for repeatability), and sample spike (for accuracy). One blank and one quality control (QC) standard sample with the mixture of phthalate metabolites (100 ng/mL) were included in each batch of samples analyzed. Recovery of 13 C12-labeled internal-standard and native-standard of each phthalate metabolite in samples was higher than 85%. The phthalate metabolite levels of the blank samples were lower than twice the minimum detectable limit in each batch. The intra-and interassay coefficients of variation for the measurements of MEP, MBP, MBzP, and MEHHP in urine samples were 2% to 28%, 3% to 15%, 9% to 16%, and 10% to 20%. The calibration range of all phthalate metabolites was 0.2-1000 ppb. The R 2 was greater than 0.99 on each analyte. The limit of detection (LOD) for MEP, MBP, MBzP, MEHHP were 3.27, 0.95, 0.15, and 1.36 ng/mL. For concentrations below the detection limits, a value of half the lower limit of detection was assigned. The limit of quantitation (LOQ) for MEP, MBP, MBzP, MEHHP were 8.30, 1.77, 0.47, and 4.14 ng/mL. LOQ was determined based on signal-to-noise approach. Determination of the signal-to-noise ratio (10:1) was performed by comparing measured signals from samples with known low concentrations of analyte with those of blank samples and by establishing the minimum concentration at which the analyte can be reliably quantified. All results involved duplicate analysis. Regarding the procedure for avoiding contamination, the adsorbent was washed with twice of 0.1% NH4OH in methanol and twice of Milli-Q water. All glassware was rinsed with acetone and methanol sequentially after washing and before the use. All adsorbent plate was disposed after the extraction. Each batch of samples contained a reagent blank, matrix blank, two matrix spike samples, sample duplicate, and sample spike. No contamination of analytes was identified. Urine creatinine levels were analyzed by enzymatic assay according to the manufacturers' instructions (Cayman Chemical, Ann Arbor, MI, USA) [1] . All statistical models were adjusted for urine creatinine levels.
